Happify Health's Director of Clinical Operations provides an in-depth look into the DTx industry, addressing questions such as:

  • Is a defined bar of validation set for digital therapeutic clinical trials?
  • Should FDA and non-FDA regulated digital therapeutics require different levels of validation or should it be uniform?
  • What are the current requirements for DTx clinical trials to be considered successful?

 


Request a demo to learn more about how Happify Health is committed to helping  people heal, one person at a time.

 

 

New call-to-action